"Pfizer is ending its work with research contractor Care Access on an 18,000-patient Lyme disease vaccine trial, according to an internal email reviewed by Endpoints News, widening the breach that has emerged between the drug giant and the richly-valued research startup in recent days."

https://endpts.com/pfizer-cuts-cro-unicorn-fr...r-conduct/